stella
beta
Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study) — Stella
Home
/
Coronary Microvascular Dysfunction
/
View on ClinicalTrials.gov
Recruiting
Back to Coronary Microvascular Dysfunction trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
Netherlands
University Medical Center Utrecht, Utrecht
Poland
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu, Warsaw